Product Images Tivicay

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 12 images provide visual information about the product associated with Tivicay NDC 67296-1818 by Redpharm Drug, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

3 COUNT - 67296 1818 3

3 COUNT - 67296 1818 3

NDC 67296-1818-3 is the identifier for TIVICAY, a prescription medicine in the form of 50mg tablets. Each package contains three tablets, with Lot TS4PX1 and an expiration date of 03/25. Adult dosages are indicated in the package insert. The medicine should be stored at a controlled room temperature of 20-25°C (68-77°F). The manufacturer is GlaxoSmithKline, with an address of 25 Research Triangle Park, NC 27709. The distributor is Redpharm Drug, and the product ID is SIN136754. No additional information is available.*

dolutegravir chemical structure - tivicay spl graphic 01

dolutegravir chemical structure - tivicay spl graphic 01

Tivicay pack - tivicay spl graphic 02

Tivicay pack - tivicay spl graphic 02

Figure A - tivicay spl graphic 03

Figure A - tivicay spl graphic 03

Figure B and Figure C - tivicay spl graphic 04

Figure B and Figure C - tivicay spl graphic 04

Figure D - tivicay spl graphic 05

Figure D - tivicay spl graphic 05

The text provides a simple instruction to give medicine to a child.*

Figure E and Figure F - tivicay spl graphic 06

Figure E and Figure F - tivicay spl graphic 06

Simple instruction to administer medicine to an infant.*

Figure G and Figure H - tivicay spl graphic 07

Figure G and Figure H - tivicay spl graphic 07

Tivicay PD 5 mg 60 count carton - tivicay spl graphic 08

Tivicay PD 5 mg 60 count carton - tivicay spl graphic 08

Tivicay PD is a prescription drug that comes in a bottle of 60 tablets and a dosing syringe. Each tablet contains 5mg of dolutegravir. It is important not to chew, cut, or crush this tablet for oral suspension. Tivicay and Tivicay PD are not interchangeable. Prescription information should be followed closely.*

Tivicay 10 mg 30 count label - tivicay spl graphic 09

Tivicay 10 mg 30 count label - tivicay spl graphic 09

Tivicay (dolutegravir) Tablets are available in a pack of 30 and each film-coated tablet contains dolutegravir sodium equivalent to 10 mg of dolutegravir. It is preferably stored in its original package at a controlled room temperature of 25°C (77°F) excursions permitted to 1510 30°C (59'086'F) (as per the USP). The bottle should be kept tightly closed and protected from moisture. The prescribing information should be referred to for dosage information. This medication is only available on prescription.*

Tivicay 25 mg count label - tivicay spl graphic 10

Tivicay 25 mg count label - tivicay spl graphic 10

This is a prescription drug labeled as "Ivicay" with the generic name "dolutegravir". It comes in the form of film-coated tablets containing 25 mg of dolutegravir sodium per tablet. The medication should be stored at a controlled room temperature between 25°C (77°F) and excursions allowed between 10-30°C (59° to 86°F). The prescribing information should be consulted for dosage instructions. The drug is manufactured in Japan by Viv ExE and the contact information is mentioned for Research Triangle Park, NC 27709.*

Tivicay 50 mg 30 count label - tivicay spl graphic 11

Tivicay 50 mg 30 count label - tivicay spl graphic 11

This is a prescription medicine called Tivicay with the generic name dolutegravir which comes in tablets of 50 mg. The bottle contains 30 tablets and suggests storing at controlled room temperature between 15 to 30°C (59° to 86°F). The manufacturer is ViiV Healthcare located in RTP, NC. This medicine is specifically used for treating HIV infection. Please check the prescribing information for the dosage. Some contact information is also included on the label.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.